Core Scientific, Inc. (CORZ)
NASDAQ: CORZ · Real-Time Price · USD
20.18
+0.40 (2.02%)
At close: Aug 14, 2026, 4:00 PM EDT
20.20
+0.02 (0.10%)
After-hours: Aug 14, 2026, 7:55 PM EDT
Core Scientific Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 289.07 | 89.81 | 101.93 | 112.07 | 242.52 | 327.56 |
Other Revenue | 151.24 | 229.21 | 408.74 | 390.33 | 397.8 | 216.93 |
| 440.31 | 319.02 | 510.67 | 502.4 | 640.31 | 544.48 | |
Revenue Growth | 26.37% | -37.53% | 1.65% | -21.54% | 17.60% | 802.66% |
Cost of Revenue | 298.81 | 264.43 | 376.99 | 378.94 | 631.91 | 305.62 |
Gross Profit | 141.5 | 54.59 | 133.68 | 123.46 | 8.4 | 238.86 |
Selling, General & Admin | 215.68 | 199.29 | 131.13 | 108.11 | 223.71 | 64.55 |
Research & Development | - | - | - | - | 26.96 | 7.67 |
Other Operating Expenses | 66.64 | 31.6 | 3.81 | 4.43 | 187.02 | 32.39 |
Operating Expenses | 282.32 | 230.89 | 134.93 | 112.54 | 437.69 | 104.61 |
Operating Income | -140.82 | -176.3 | -1.25 | 10.92 | -429.29 | 134.25 |
Interest Expense | -39.25 | - | -37.07 | -86.24 | -96.83 | -44.35 |
Interest & Investment Income | 10.46 | 3.28 | - | - | - | - |
Currency Exchange Gain (Loss) | - | - | - | - | -28.03 | -0.12 |
Other Non Operating Income (Expenses) | -820.72 | -33.1 | -1,367 | 2.53 | 42.2 | -0 |
EBT Excluding Unusual Items | -990.32 | -206.12 | -1,405 | -72.79 | -511.94 | 89.77 |
Merger & Restructuring Charges | - | - | - | - | -6.8 | - |
Impairment of Goodwill | - | - | - | - | -1,055 | - |
Gain (Loss) on Sale of Assets | -39.91 | -9.68 | -4.21 | -1.96 | - | - |
Asset Writedown | -277.85 | -11.36 | -122.87 | - | -590.74 | - |
Legal Settlements | -11.19 | -10.69 | -2.07 | - | - | -2.64 |
Other Unusual Items | -108.57 | -50.18 | 97.22 | -171.06 | 0.77 | -24.06 |
Pretax Income | -1,428 | -288.03 | -1,437 | -245.8 | -2,163 | 63.08 |
Income Tax Expense | 2.73 | 0.58 | 0.86 | 0.68 | -17.09 | 15.76 |
Net Income | -1,431 | -288.62 | -1,438 | -246.49 | -2,146 | 47.31 |
Preferred Dividends & Other Adjustments | 202.23 | -7.88 | -192.59 | - | - | - |
Net Income to Common | -1,633 | -280.74 | -1,245 | -246.49 | -2,146 | 47.31 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 322 | 318 | 256 | 380 | 341 | 207 |
Shares Outstanding (Diluted) | 322 | 318 | 256 | 380 | 341 | 233 |
Shares Change | 3.62% | 24.33% | -32.65% | 11.51% | 46.01% | 48.03% |
EPS (Basic) | -5.07 | -0.88 | -4.87 | -0.65 | -6.30 | 0.23 |
EPS (Diluted) | -5.07 | -0.88 | -4.87 | -0.65 | -6.30 | 0.20 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -957.75 | -450.75 | -52.07 | 48.95 | -396.47 | -56.74 |
Free Cash Flow Per Share | -2.98 | -1.42 | -0.20 | 0.13 | -1.16 | -0.24 |
Gross Margin | 32.14% | 17.11% | 26.18% | 24.57% | 1.31% | 43.87% |
Operating Margin | -31.98% | -55.26% | -0.24% | 2.17% | -67.04% | 24.66% |
Profit Margin | -370.83% | -88.00% | -243.85% | -49.06% | -335.20% | 8.69% |
Free Cash Flow Margin | -217.52% | -141.29% | -10.20% | 9.74% | -61.92% | -10.42% |
EBITDA | -78.25 | -107.39 | 111.95 | 106.92 | -204.03 | 167.61 |
EBITDA Margin | -17.77% | -33.66% | 21.92% | 21.28% | -31.86% | 30.78% |
D&A For EBITDA | 62.57 | 68.91 | 113.21 | 96 | 225.26 | 33.36 |
EBIT | -140.82 | -176.3 | -1.25 | 10.92 | -429.29 | 134.25 |
EBIT Margin | -31.98% | -55.26% | -0.24% | 2.17% | -67.04% | 24.66% |
Effective Tax Rate | - | - | - | - | - | 24.99% |
Revenue as Reported | 440.31 | 319.02 | 510.67 | 502.4 | 640.31 | 544.48 |